Abstracts tagged "Sjogren’s syndrome and natural killer (NK) cells"

Abstract Number: 1456 • 2019 ACR/ARP Annual Meeting
The Increased Ratio of Blood CD56bright to CD56dim NK Cells Is a Distinguishing Feature of Primary Sjögren’s Syndrome
Bingxia Ming ¹, Tong Wu ¹ and Lingli Dong², ¹Department of Rheumatology and Immunology, Tongji hospital, Huazhong university of science and technology, Wuhan, China (People's Republic), ²Department of Rheumatology and Immunology, Tongji hospital, Huazhong university of science and technology, Wuhan, Hubei, China (People's Republic)
Background/Purpose: To investigate the characteristic and clinical significance of peripheral blood CD56 NK cell subsets in patients with primary Sjögren's syndrome (pSS).Methods: From November 2017…
Abstract Number: 2771 • 2013 ACR/ARHP Annual Meeting
The NKp30/B7H6 Axis Contributes To Pathogenesis In Primary Sjögren’s Syndrome
Gaetane Nocturne¹, Sylvie Rusakiewicz², Damien Sene³, Gunnel Nordmark⁴, Maija-Leena Eloranta⁵, Per Eriksson⁶, Elke Theander⁷, Helena Forsblad-d'Elia⁸, Roald Omdal⁹, Marie Wahren-Herlenius¹⁰, Roland Jonsson¹¹, Lars Rönnblom⁵, Joanne Nititham¹², Kimberly E. Taylor¹³, Christopher J. Lessard¹⁴, Kathy L. Moser¹⁵, Jacques-Eric Gottenberg¹⁶, Lindsey A. Criswell¹², Corinne Miceli-Richard¹⁷, Laurence Zitvogel¹⁸ and Xavier Mariette¹⁹, ¹INSERM U1012, Université Paris Sud, Le Kremlin Bicêtre, France, ²IGR INSERM U1015, Villejuif, France, ³Internal Medecine, Pitie-Salpetriere Hospital, Paris, France, ⁴Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, ⁵Department of Medical Sciences, Section of Rheumatology, Uppsala University, Uppsala, Sweden, ⁶Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping University, Linköping, Sweden, Linköping, Sweden, ⁷Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ⁸Rheumatology, University of Gothenburg, Gothenburg, Sweden, ⁹Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, ¹⁰Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, ¹¹Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway, ¹²Department of Medicine, University of California, San Francisco, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA, ¹³University of California, San Francisco, San Francisco, CA, ¹⁴Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹⁵Oklahoma Medical Research Foundation, Oklahoma City, OK, ¹⁶Strasbourg University Hospital, Strasbourg, France, ¹⁷Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, ¹⁸IGR INSERM U1015, Villejuif, France, ¹⁹Rheumatology Service, Bicêtre University Hospital, Le Kremlin Bicetre, France
Background/Purpose: NK cells are an important subset of cells involved in innate immunity. Their possible role has never been studies in pSS pathogeny. We aimed…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].